Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

AGM Statement

6 Sep 2006 07:00

Embargoed Release: 0700hrs, 6 September 2006 Nanoscience Inc. (`Nanoscience' or the `Group') AGM Statement At the Annual General Meeting of Nanoscience Inc. being held today, the Group'sChairman will make the following statement to the meeting:"I am pleased to be able to report to our shareholders that the Group'sforthcoming interim results for the six months to 30 June 2006 will be in linewith your Board's expectations and we have continued to deliver furtherprogress in all aspects of our business. Nanoscience continues to establish arobust track record in its ability to identify niche investment opportunitieswith the potential for substantial growth. Our focus on supporting emergingtechnologies with strong commercial propositions is enabling us to add furthervalue to our investee companies in the form of managerial guidance.Throughout the interim period there has been a positive maturing andstrengthening of our portfolio. Our investment in Future Waves was announced inMarch and the company subsequently achieved early successes in winning`design-ins' for its Fenix 1 chip in the Far East, with a positive receptionfrom manufacturers of MP3, GPS and multimedia systems.The ongoing testing of Toumaz's Sensium chip continues to demonstrate betterthan expected results. Significant customer interest in this product continuesto build and your Board remains confident that the trials currently beingundertaken by these potential customers will ultimately be converted intocommercial transactions.AppliedSensor, the Group's first investment, has successfully completed producttesting within the automotive industry and orders have been received from twokey leading manufacturers. A first production order has also been received froma leading supplier in the indoor air quality control sector.The aforementioned developments demonstrate the fast evolution of the investeecompanies within the Group's portfolio and the real opportunity to deliverenhanced shareholder value through our strategy of making investments inemerging technologies where we can add value in the commercialisation process.Financially, Nanoscience remains on track with regard to its cash utilization,which is in line with our 2006 budget, and we remain confident about the futurepotential of the Group.The hard work, dedication and enthusiasm shown by employees in all our investeecompanies is moving our portfolio forwards at the pace we would expect, and wethank them for their efforts." -Ends- Further Information:Richard Rose Nanoscience 07836 250 474 Ben Simons Hansard Communications 020 7245 1100 ENDNANOSCIENCE INC
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSTrading update
13th Feb 20127:00 amRNSPlacing raises £11.2m
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSYear End Trading Update
1st Feb 20117:00 amRNSTELRAN Launch
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.